MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Heatmap
  • Русский
  • 中文
  • Español
  • Português
  • 日本語
  • Deutsch
  • 한국어
  • Français
  • Italiano
  • Türkçe
Protagonist Therapeutics, Inc

PTGX

#1151
Protagonist Therapeutics, Inc. - Common Stock
100.3 5 USD
-0.06%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
99.93
102.40
Year Range
1.00
107.84
Daily Change
-0.06%
Monthly Change
+1.39%
6 month change
+11.99%
Year Change
+33.57%
Previous Close
100.4 1
Open
100.6 4
Low
99.9 3
High
102.4 0
Volume
68
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. PTGX
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 6.45 B
  • Employee 131
  • Founded 2006
  • CEO N/A
  • Website www.protagonist-inc.com
  • Headquarter Delaware, United States
  • FIGI BBG002B63KM7
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-42.6
Price to sales ratio
120.66

News

Zacks Zacks
JNJ AMGN TEVA PTGX
yesterday, 12:21
J&J Stock Gains Nearly 12% Year to Date: Buy, Sell or Hold Now?
WSJ WSJ
ABBV JNJ PTGX LEGN
yesterday, 09:30
J&J Mastered Cancer Biotech Deals on the Cheap. Can It Stay on the Cutting Edge?
Zacks Zacks
JNJ PFE PTGX
2026.05.22
J&J & Pfizer Face Patent Risks: Which Stock Looks Better Positioned?
Zacks Zacks
JNJ ABBV PTGX
2026.05.19
J&J's Pipeline Progress & New Drugs Promise Stronger Long-Term Growth
Zacks Zacks
JNJ PFE LLY PTGX
2026.05.12
Tremfya, Icotyde Lead J&J's Post-Stelara Immunology Strategy
Zacks Zacks
JNJ AMGN TEVA PTGX
2026.04.20
How to Play J&J Stock Post a Beat-and-Raise Performance in Q1
Seeking Alpha Seeking Alpha
JNJ
S
ALVO TEVA AMGN
2026.04.17
Johnson & Johnson: Why I See Downside Ahead (NYSE:JNJ)
MarketWatch MarketWatch
KMB JNJ ABBV PTGX
500
2026.04.14
J&J raises guidance for 2026 on strong start to the year
Zacks Zacks
JNJ NVO LLY PTGX
2026.04.13
Growth vs. Stability: Lilly and J&J's 2026 Investment Face-Off
Zacks Zacks
AZN JNJ ABBV PTGX
2026.03.27
Can New Drugs Drive J&J's Innovative Medicine Despite Stelara LOE?
Zacks Zacks
JNJ ABBV PTGX
2026.03.26
J&J's Pipeline Surge Sets Up Stronger Growth From New Drugs in 2026
Zacks Zacks
JNJ AMGN TEVA PTGX
2026.03.24
J&J Stock Trading Above 200- & 50-Day SMA for 8 Months: Time to Buy?

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Store
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
MQL5 Channels
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Economic Calendar
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Risk Disclosure Terms of Use Help Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd